Zyneyro ApS: Financial statements 2025
CVR: 42057428
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
Zyneyro ApS (CVR 42057428) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -4,550,684 and a net result of DKK -7,466,446 compared with DKK 665,931 the year before. Equity in the 2025 report amounted to DKK 4,147,370. The solvency ratio was 78.7%.
- Gross Profit
- DKK -4,550,684
- Profit/Loss
- DKK -7,466,446
- Equity
- DKK 4,147,370
- Total Assets
- DKK 5,269,122
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -4.6 mio. | -7.5 mio. | 4.1 mio. | 0 |
| 2024 | - | 4.2 mio. | 666 t. | 614 t. | 5 |
| 2023 | - | 1 mio. | -35 t. | -52 t. | 4 |
| 2022 | - | -27 t. | -28 t. | -18 t. | 0 |
| 2021 | - | -27 t. | -29 t. | 11 t. | 0 |
Official annual report
How creditworthy is Zyneyro ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
As of July 1, 2025, Erik Vinther has joined the board of directors of Zyneyro ApS.
Zyneyro ApS has published its annual report for 2024. Gross profit came to DKK 4,168,667, and the net result was DKK 665,931.
As of May 12, 2025, Revisionsfirmaet Tom Sønderup I/S has stepped down as auditor of Zyneyro ApS.
About Zyneyro ApS
Zyneyro ApS is a Danish company of the type Anpartsselskab based in København N, founded in 2021. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named DolorestBio ApS. The management consists of Steen Søren Klysner. The board consists of Jacob Ørndrup (chair), Andreas Toft Sørensen, Erik Vinther and Kenneth Lindegaard Madsen. The company's owners include Marigold Innovation ApS, IFO ApS and UGether ApS. The company has 10 employees (2026). In 2025, the company reported a gross profit of DKK -4,550,684 and a net result of DKK -7,466,446 compared with DKK 665,931 the year before. Equity in the 2025 report amounted to DKK 4,147,370.